• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Averting a malaria disaster.

作者信息

White N J, Nosten F, Looareesuwan S, Watkins W M, Marsh K, Snow R W, Kokwaro G, Ouma J, Hien T T, Molyneux M E, Taylor T E, Newbold C I, Ruebush T K, Danis M, Greenwood B M, Anderson R M, Olliaro P

机构信息

Wellcome-Mahidol University Oxford Tropical Medicine Research Programme, Mahidol University, Bangkok, Thailand.

出版信息

Lancet. 1999 Jun 5;353(9168):1965-7. doi: 10.1016/s0140-6736(98)07367-x.

DOI:10.1016/s0140-6736(98)07367-x
PMID:10371589
Abstract
摘要

相似文献

1
Averting a malaria disaster.避免疟疾灾难。
Lancet. 1999 Jun 5;353(9168):1965-7. doi: 10.1016/s0140-6736(98)07367-x.
2
Artemether treatment of sulfadoxine/pyrimethamine-resistant Plasmodium falciparum malaria in children.蒿甲醚治疗儿童对磺胺多辛/乙胺嘧啶耐药的恶性疟原虫疟疾
Trans R Soc Trop Med Hyg. 1995 Jul-Aug;89(4):435-6. doi: 10.1016/0035-9203(95)90044-6.
3
WHO, the Global Fund, and medical malpractice in malaria treatment.世界卫生组织、全球基金与疟疾治疗中的医疗事故
Lancet. 2004 Jan 17;363(9404):237-40. doi: 10.1016/S0140-6736(03)15330-5.
4
Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.在恶性疟原虫和间日疟原虫共同流行地区，磺胺多辛-乙胺嘧啶联合青蒿琥酯与氯喹治疗间日疟的疗效比较：阿富汗东部的一项随机非劣效性试验
Trans R Soc Trop Med Hyg. 2007 Nov;101(11):1081-7. doi: 10.1016/j.trstmh.2007.06.015. Epub 2007 Aug 17.
5
Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.单纯性恶性疟的治疗：在印度尼西亚伊里安查亚进行的一项随机试验，比较青蒿琥酯加磺胺多辛-乙胺嘧啶与单用磺胺多辛-乙胺嘧啶的疗效。
Am J Trop Med Hyg. 2001 Oct;65(4):309-17. doi: 10.4269/ajtmh.2001.65.309.
6
Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.单独使用周效磺胺/乙胺嘧啶或联合阿莫地喹或青蒿琥酯治疗非复杂性疟疾：一项纵向随机试验
Lancet. 2002;360(9350):2031-8. doi: 10.1016/S0140-6736(02)12021-6.
7
Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.青蒿琥酯-阿莫地喹与氯喹-乙胺嘧啶-磺胺多辛治疗尼日利亚儿童单纯性恶性疟原虫疟疾的开放随机研究
Trop Med Int Health. 2005 Nov;10(11):1161-70. doi: 10.1111/j.1365-3156.2005.01503.x.
8
Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.青蒿琥酯联合阿莫地喹与氯喹、阿莫地喹或磺胺多辛-乙胺嘧啶单药治疗阿富汗非复杂性恶性疟原虫感染的疗效比较。
Trop Med Int Health. 2005 Jun;10(6):521-9. doi: 10.1111/j.1365-3156.2005.01429.x.
9
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.氯喹、周效磺胺/乙胺嘧啶、甲氟喹及甲氟喹-青蒿琥酯治疗缅甸北部克钦邦恶性疟的比较
Trop Med Int Health. 2004 Nov;9(11):1184-90. doi: 10.1111/j.1365-3156.2004.01323.x.
10
Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.青蒿琥酯加磺胺多辛-乙胺嘧啶与单用磺胺多辛-乙胺嘧啶治疗秘鲁非复杂性恶性疟的疗效和耐受性
Am J Trop Med Hyg. 2005 May;72(5):568-72.

引用本文的文献

1
Hybrid Molecules as Efficient Drugs against Multidrug-Resistant Malaria Parasites.作为抗多药耐药疟原虫有效药物的杂合分子
ChemMedChem. 2025 Jun 2;20(11):e202500086. doi: 10.1002/cmdc.202500086. Epub 2025 Apr 14.
2
Artesunate-loaded thermosensitive chitosan hydrogel promotes osteogenesis of maxillary tooth extraction through regulating T lymphocytes in type 2 diabetic rats.载青蒿琥酯的温敏壳聚糖水凝胶通过调节 2 型糖尿病大鼠 T 淋巴细胞促进上颌拔牙后骨再生。
BMC Oral Health. 2024 Mar 20;24(1):356. doi: 10.1186/s12903-024-04127-7.
3
Mathematical modelling of antibiotic interaction on evolution of antibiotic resistance: an analytical approach.
抗生素相互作用对抗生素耐药性进化的数学建模：一种分析方法。
PeerJ. 2024 Feb 26;12:e16917. doi: 10.7717/peerj.16917. eCollection 2024.
4
A case report of late treatment failure in malaria in a traveler from the Democratic Republic of the Congo to India.一名从刚果民主共和国前往印度的旅行者疟疾晚期治疗失败的病例报告。
IDCases. 2022 Dec 16;31:e01653. doi: 10.1016/j.idcr.2022.e01653. eCollection 2023.
5
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.2016 至 2017 年，在肯尼亚西部，青蒿琥酯-咯萘啶与双氢青蒿素-哌喹治疗儿童无并发症恶性疟原虫疟疾的疗效。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0020722. doi: 10.1128/aac.00207-22. Epub 2022 Aug 29.
6
Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria.治疗无并发症恶性疟原虫疟疾的三联和多药物组合在临床开发路径上面临的挑战。
Malar J. 2022 Feb 22;21(1):61. doi: 10.1186/s12936-022-04079-9.
7
Efficacy and safety of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis.在埃塞俄比亚，青蒿琥酯-咯萘啶治疗无并发症恶性疟原虫疟疾的疗效和安全性：系统评价和荟萃分析。
Malar J. 2021 May 6;20(1):213. doi: 10.1186/s12936-021-03745-8.
8
Plasmodium falciparum Isolates Carrying k13 Polymorphisms Harbor the SVMNT Allele of in Northwestern Indonesia.在印度尼西亚西北部，携带 k13 多态性的恶性疟原虫分离株携带 SVMNT 等位基因。
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.02539-19.
9
When "Good Evidence" Is Not Enough: A Case of Global Malaria Policy Development.当“充分证据”并不充分时：一个全球疟疾政策制定的案例
Glob Chall. 2018 Mar 22;2(9):1700077. doi: 10.1002/gch2.201700077. eCollection 2018 Sep.
10
PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?吡喹酮疗法：我们在有效替代抗血吸虫药物的研发上进展如何？
Infect Disord Drug Targets. 2019;19(4):337-349. doi: 10.2174/1871526519666181231153139.